News from novo nordisk inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 13, 2015, 16:27 ET
Novo Nordisk, Inc.

One World Trade Center to Glow Blue in Honor of World Diabetes Day on November 14, 2015

 On Saturday, November 14, 2015, the spire of One World Trade Center will be lit in blue, the official color of diabetes, to raise awareness of...

Nov 10, 2015, 11:00 ET
Novo Nordisk, Inc.

Emerging Data Could Begin to Redefine how Cities Address the Growing Diabetes Epidemic

 New research conducted in collaboration with the University of Texas Health Science Center at Houston (UTHealth) School of Public Health finds...

Nov 10, 2015, 08:00 ET
Novo Nordisk, Inc.

Great Place to Work® and Fortune Name Novo Nordisk as One of the 50 Best Workplaces for Diversity in US

 Novo Nordisk is honored to announce that Great Place to Work® and Fortune have recognized it as one of the 50 Best Workplaces for...

Nov 04, 2015, 12:30 ET

New study finds that many people with obesity consider themselves healthy despite having obesity-related comorbidities

Initial data from Awareness, Care & Treatment In Obesity Management (ACTION), the first nationwide U.S. study to investigate barriers to...

Nov 04, 2015, 12:30 ET

Data presented at ObesityWeek showed Saxenda® (liraglutide [rDNA origin] injection) treatment demonstrated significant and sustained weight loss over three years compared with placebo

 Today, new data from the phase 3a SCALE™ (Satiety and Clinical Adiposity: Liraglutide Evidence in Non-Diabetic and Diabetic adults)...

Sep 29, 2015, 10:00 ET
Novo Nordisk of North America logo.

Novo Nordisk Launches New Medical Resource for People Living with Hemophilia and Other Rare Bleeding Disorders

Novo Nordisk today announced the launch of, a website providing a range of medical information specifically for people in...

Sep 25, 2015, 18:57 ET

Novo Nordisk Receives FDA Approval for Tresiba® (insulin degludec injection) for Adults with Type 1 and Type 2 Diabetes

 Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration (FDA) approved the new drug...

Jul 21, 2015, 08:30 ET
Novo Nordisk, Inc.

Novo Nordisk and NBA Legend Dominique Wilkins Launch My Diabetes Dream Team Sweepstakes

Novo Nordisk, a world leader in diabetes care, has teamed up with NBA Hall of Famer and 9-time All-Star Dominique Wilkins to help adults with type...

Jul 16, 2015, 11:56 ET
Novo Nordisk, Inc.

Novo Nordisk Receives FDA Approval for FlexPro® PenMate® for People with Growth Hormone-Related Disorders

Novo Nordisk announced today the U.S. Food and Drug Administration (FDA) approval of FlexPro® PenMate®, designed for users of...

Jun 24, 2015, 09:00 ET

New Novo Nordisk Data Demonstrate Caregiver Burden and Prevalence of Pain in People Living With Hemophilia

Today, Novo Nordisk presented new data detailing the impact hemophilia has on both caregivers and those living with the disease. Results from 2...

Jun 24, 2015, 07:30 ET

In a Phase 3 Trial, Novoeight®(Antihemophilic Factor [Recombinant]) Provided Long-term Efficacy and Safety in the Prophylaxis and Treatment of Bleeds in People with Hemophilia A

Today, at the International Society on Thrombosis and Haemostasis (ISTH) 2015 Congress, Novo Nordisk announced the latest interim data from the...

Jun 23, 2015, 13:55 ET
Novo Nordisk, Inc.

Great Place to Work® and Fortune Name Novo Nordisk as One of the 100 Best Workplaces for Millennials in the US

 In just 10 years, millennials will make up 75 percent of the workforce. To compete for top talent and ensure their long-term success,...

Jun 07, 2015, 08:00 ET

New IDegLira Phase 3b Study Showed Statistically Significant HbA1c Reduction, Body Weight Change, and Lower Rate of Hypoglycaemia Versus Insulin Glargine

- 166-OR For medical and consumer media in the US only  New phase 3b findings showed adults with type 2 diabetes treated with IDegLira, the...

Jun 06, 2015, 10:00 ET

New Study With Victoza® (Liraglutide [rDNA Origin] Injection) Showed Improvements in Blood Glucose Control in Adults With Type 2 Diabetes Who Fasted During Ramadan

Only for US media Abstract #1121-P New findings showed that adults with type 2 diabetes treated with Victoza® (liraglutide [rDNA origin]...

May 15, 2015, 12:10 ET

New analysis of data in adults with obesity or who are overweight with weight-related comorbidities showed early response to Saxenda® (liraglutide [rDNA origin] injection) predicted greater weight loss

 Today, new data from the phase 3a SCALE™ Obesity and Pre-diabetes trial were presented at the 24th Annual Scientific and Clinical...

Apr 22, 2015, 09:00 ET
Saxenda(R) (liraglutide [rDNA origin] injection) logo. Please see full Prescribing Information, including Boxed Warning, for Saxenda(R) at

Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States

Novo Nordisk today announced that Saxenda® (liraglutide [rDNA origin] injection) is now available in the United States. Saxenda® is the...

Apr 17, 2015, 09:00 ET

Novo Nordisk Celebrates World Hemophilia Day and Shares New Support Programs, Including HeroPath™ and Career Counseling

 Novo Nordisk is proud to celebrate World Hemophilia Day, which aims to raise awareness of the disease and other inherited bleeding disorders....

Apr 14, 2015, 03:00 ET
Novo Nordisk Logo

Novo Nordisk Extends Programme for Children With Diabetes in Developing Countries

Today, Novo Nordisk announced a three-year extension of its Changing Diabetes® in Children programme. Since 2009, free insulin and access to...

Mar 26, 2015, 12:47 ET

Novo Nordisk to Launch Novoeight® in the United States for People With Hemophilia A

 Novo Nordisk today announced the company will launch Novoeight® (Antihemophilic Factor [Recombinant]) in the United States for people...

Mar 07, 2015, 16:00 ET